Colis Laureen C, Raychaudhury Paromita, Basu Ashis K
Department of Chemistry, University of Connecticut, Storrs, Connecticut 06269, USA.
Biochemistry. 2008 Aug 5;47(31):8070-9. doi: 10.1021/bi800529f. Epub 2008 Jul 11.
Comparative mutagenesis of gamma- or X-ray-induced tandem DNA lesions G[8,5-Me]T and T[5-Me,8]G intrastrand cross-links was investigated in simian (COS-7) and human embryonic (293T) kidney cells. For G[8,5-Me]T in 293T cells, 5.8% of progeny contained targeted base substitutions, whereas 10.0% showed semitargeted single-base substitutions. Of the targeted mutations, the G --> T mutation occurred with the highest frequency. The semitargeted mutations were detected up to two bases 5' and three bases 3' to the cross-link. The most prevalent semitargeted mutation was a C --> T transition immediately 5' to the G[8,5-Me]T cross-link. Frameshifts (4.6%) (mostly small deletions) and multiple-base substitutions (2.7%) also were detected. For the T[5-Me,8]G cross-link, a similar pattern of mutations was noted, but the mutational frequency was significantly higher than that of G[8,5-Me]T. Both targeted and semitargeted mutations occurred with a frequency of approximately 16%, and both included a dominant G --> T transversion. As in 293T cells, more than twice as many targeted mutations in COS cells occurred in T[5-Me,8]G (11.4%) as in G[8,5-Me]T (4.7%). Also, the level of semitargeted single-base substitutions 5' to the lesion was increased and 3' to the lesion decreased in T[5-Me,8]G relative to G[8,5-Me]T in COS cells. It appeared that the majority of the base substitutions at or near the cross-links resulted from incorporation of dAMP opposite the template base, in agreement with the so-called "A-rule". To determine if human polymerase eta (hpol eta) might be involved in the mutagenic bypass, an in vitro bypass study of G[8,5-Me]T in the same sequence was carried out, which showed that hpol eta can bypass the cross-link incorporating the correct dNMP opposite each cross-linked base. For G[8,5-Me]T, nucleotide incorporation by hpol eta was significantly different from that by yeast pol eta in that the latter was more error-prone opposite the cross-linked Gua. The incorporation of the correct nucleotide, dAMP, by hpol eta opposite cross-linked T was 3-5-fold more efficient than that of a wrong nucleotide, whereas incorporation of dCMP opposite the cross-linked G was 10-fold more efficient than that with dTMP. Therefore, the nucleotide incorporation pattern by hpol eta was not consistent with the observed cellular mutations. Nevertheless, at and near the lesion, hpol eta was more error-prone compared to a control template. The in vitro data suggest that translesion synthesis by another Y-family DNA polymerase and/or flawed participation of an accessory protein is a more likely scenario in the mutagenesis of these lesions in mammalian cells. However, hpol eta may play a role in correct bypass of the cross-links.
在猴肾(COS - 7)细胞和人胚胎肾(293T)细胞中,研究了γ射线或X射线诱导的串联DNA损伤G[8,5 - 甲基]T和T[5 - 甲基,8]G链内交联的比较诱变情况。对于293T细胞中的G[8,5 - 甲基]T,5.8%的子代含有靶向碱基替换,而10.0%表现出半靶向单碱基替换。在靶向突变中,G→T突变出现的频率最高。半靶向突变在交联位点5'端最多两个碱基和3'端最多三个碱基处被检测到。最常见的半靶向突变是紧挨着G[8,5 - 甲基]T交联位点5'端的C→T转换。还检测到了移码突变(4.6%)(大多为小缺失)和多碱基替换(2.7%)。对于T[5 - 甲基,8]G交联,观察到了类似的突变模式,但突变频率显著高于G[8,5 - 甲基]T。靶向和半靶向突变的发生频率均约为16%,且都包含占主导的G→T颠换。与293T细胞一样,COS细胞中T[5 - 甲基,8]G(11.4%)发生的靶向突变是G[8,5 - 甲基]T(4.7%)的两倍多。此外,相对于G[8,5 - 甲基]T,COS细胞中T[5 - 甲基,8]G损伤5'端的半靶向单碱基替换水平增加,而3'端的则降低。似乎交联位点处或其附近的大多数碱基替换是由于与模板碱基相对应的dAMP掺入导致的,这与所谓的“A规则”一致。为了确定人类聚合酶η(hpol η)是否可能参与诱变绕过过程,对相同序列中的G[8,5 - 甲基]T进行了体外绕过研究,结果表明hpol η可以绕过交联,在每个交联碱基相对处掺入正确的dNMP。对于G[8,5 - 甲基]T,hpol η的核苷酸掺入与酵母聚合酶η显著不同,后者在交联的鸟嘌呤相对处更容易出错。hpol η在交联的胸腺嘧啶相对处掺入正确核苷酸dAMP的效率比掺入错误核苷酸高3 - 5倍,而在交联的鸟嘌呤相对处掺入dCMP的效率比掺入dTMP高10倍。因此,hpol η的核苷酸掺入模式与观察到的细胞突变不一致。然而,在损伤位点处及附近,与对照模板相比,hpol η更容易出错。体外数据表明,另一种Y家族DNA聚合酶的跨损伤合成和/或辅助蛋白的缺陷参与在哺乳动物细胞中这些损伤的诱变过程中是更有可能的情况。然而,hpol η可能在交联的正确绕过中发挥作用。